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Studies performed in the past two decades in animal models and in man have 
established the occurrence of two  major forms of immunologically mediated 
glomerular disease;  one  results  from  the  accumulation of antigen-antibody 
complexes in glomeruli (immune complex glomerulonephritis) and the other 
from the reaction of antibodies with constituents of the glomerular basement 
membrane  (anti-GBM  disease). 1 Although  it  has  been  suggested that  cell- 
mediated immunity (delayed hypersensitivity) may also  produce glomerular 
injury  (1,  2)  clear-cut evidence for this  mechanism has not been presented, 
except in renal allografts, and even in this setting only under special circum- 
stances (3). Furthermore, in most morphologic studies of glomerulonephritis no 
mention is made of accumulation of mononuclear cells in glomeruli, and this 
has been used as an argument against a role of cell-mediated mechanisms (2, 
4). Infiltrating mononuclear cells have, however, been described in glomeruli in 
some forms of experimental glomerular disease (5-10), although this provides, 
at best, indirect evidence for the operation of cell-mediated mechanisms. 
We have carried out studies based on a model of glomerular disease in rats 
that is characterized by conspicuous glomerular accumulation of mononuclear 
cells (10, 11). The disease is produced by intravenous injection of subnephrito- 
genic doses of rabbit anti-rat GBM antiserum into rats that had been previously 
immunized with rabbit gamma globulin in adjuvant. Employing a modification 
of this model in which nonimmunized rats that had received subnephritogenic 
doses of rabbit anti-GBM antiserum were given lymph node cells from donors 
immunized with rabbit gamma globulin, we have obtained evidence that cell- 
mediated mechanisms participate in the production of glomerular lesions. 
Materials and Methods 
Animals.  Female  Lewis  strain  rats,  weighing  between  140  and  200  g  (Microbiological 
Associates, Walkersville, Md.), were used in all experiments. 
* Supported by U. S. Public Health Service grants CA 19393, AM 18729, and AM 16392. 
1Abbreviations  used  in  this paper:  C3,  third  component of complement; GBM,  glomerular 
basement membrane; HBSS, Hanks' balanced salt solution; OVA, ovalbumin; PBS, phosphate- 
buffered saline; RER, rough endoplasmic reticulum; RGG, rabbit gamma globulin. 
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Preparation of  Rabbit Anti-Rat GBM Antiserum.  Rat GBM antigen preparation was obtained 
by a modification of the method of Krakower and Greenspon (12), using Sprague-Dawley rats of 
both sexes  (Charles River Breeding Laboratories,  Inc.,  Wilmington,  Mass.).  The kidneys were 
perfused with ice-cold phosphate-buffered saline (PBS), pH 7.3.  Pooled cortical tissue was forced 
through stacked mold metal sieves, 150,  100, and 200 mesh respectively, yielding a  glomerular- 
rich fraction.  The fraction was then washed four times with PBS, centrifuged at 800 rpm for 5 
min, suspended  in a  small volume of distilled water,  and then senicated to disrupt  glomerular 
cells. The resultant preparation was washed several times with distilled water and lyophilized. 
New Zealand white rabbits  were injected in the foot pads or subcutaneously  with the GBM 
preparation  in complete  Freund's  adjuvant,  each rabbit  receiving the equivalent of the GBM 
obtained from 10 rat kidneys; they were boosted on days 14 and 21 with the same dose, and bled on 
day 28. All lots of sera were combined into two pools (A and B), which were absorbed with washed 
rat  erythrocytes  and  with  a  lyophilized  rat  tubular  basement  membrane  preparation.  The 
capacity of the antisera  to react with rat  GBM  in vivo and  to produce  histologic lesions was 
investigated by intravenous injections of 0.25-1 ml of the antisera into Sprague-Dawley rats; the 
animals  were  sacrificed  4  h  to  4  days  later.  Frozen  sections  of  kidney  were  stained  with 
fluorescein-labeled goat anti-rabbit  gamma  globulin.  Typical linear staining of the GBM was 
seen  after  injection of all doses  of antisera.  No  histologic  abnormalities  were  present  in the 
kidneys in the 4-day period of observation. 
Donor Rats.  Groups  of female  Lewis rats  were  immunized  with  100  ~g of rabbit  gamma 
globulin  (RGG)  or  ovalbumin  (OVA)  (Miles  Laboratories,  Inc.,  Elkhart,  Ind.)  in  complete 
Freund's adjuvant (Difco Laboratories, Detroit, Mich.) in a total volume of 0.4 ml, divided equally 
among the four foot pads.  In addition,  0.05  ml of Bordetella pertussis  vaccine (Massachusetts 
State Health Labs., Jamaica Plain,  Mass.),  at a  concentration of 2.0  ×  101° organisms/ml,  was 
injected subcutaneously in the dorsum of each foot. 7 days later, the rats were killed to provide 
lymph node cells or serum for use in transfer experiments. Cell suspensions were prepared from 
popliteal  and  axillary lymph nodes  by mincing; the cell suspensions  were passed  through  60- 
gauge mesh and washed twice with Hanks' balanced salt solution  (HBSS).  In one experiment, 
nylon wool columns were used according to the method of Julius et al. (13) to obtain preparations 
enriched  in T  cells. 5% of the recovered cells showed surface immunofluorescence for Ig using 
fluorescein-labeled  goat  anti-rat  Ig,  as  compared  with  22%  of  the  whole  lymph  node  cell 
suspension.  Cell viability was assessed by the trypan blue exclusion test and was always >80%. 
The level of antibodies against RGG in the pooled sera of the RGG donors was determined by the 
quantitative precipitin technique (14) and was found to be 0.14 mg/ml. 
Autoradiography.  Estimation  of the degree of increase  in cells or the presence of recently 
proliferated cells within glomeruli was facilitated by the study of autoradiographs,  prepared from 
renal tissue of the recipient rats that  received three  injections of [3H]thymidine  (1  /~Ci/g body 
weight, sp act 6.7 Ci/mmol; New England Nuclear, Boston, Mass.) after the time of cell transfer. 
Autoradiographs were prepared both from paraffin- and plastic-embedded tissue. With paraffin- 
embedded  material,  4-tzm  unstained  sections  were  dipped  in  NBT-2  Kodak  Nuclear  track 
emulsion and exposed for 2 wk.  After development, the sections were stained with hematoxylin 
and eosin. With plastic-embedded tissue,  1-1zm thick sections were mounted on glass slides and 
stained with periodic acid-Schiff-iron hematoxylin (15).  The slides were dipped in total darkness 
in undiluted NTB-2 emulsion, air-dried for 24 h, packed in light tight Bakelite boxes containing 
Drierite,  and  exposed  for 3-5 wk.  All autoradiographs  were developed with  Dektol developer 
(Eastman Kodak Co., Rochester, N. Y.). 
Processing  of Tissue.  For  immunofluorescence  studies,  specimens  of  renal  cortex  were 
obtained immediately after sacrifice and frozen in OCT Compound (Ames Co., Div. of Miles Lab., 
Inc., Elkhart,  Ind.) on a  cryostat  holder; 4-1zm sections were cut and stained  with fluorescein- 
conjugated antisera to RGG, rat IgG, rat third component of complement (C3),  and rat fibrinogen 
(N. L. Cappel Laboratories Inc., Cochranville, Pa.). 
For electronmicroscopic and autoradiographic  studies,  tissue was obtained under ether anes- 
thesia just before sacrifice. The left renal pedicle was clamped and the kidney was removed. 1-mm 
thick slices were immediately fixed in formaldehyde-glutaraldehyde fixative (16), diluted 1:1 with 
0.1  M  cacodylate buffer,  pH 7.3,  for 3  h  at  4°C.  They  were then  washed  overnight  in 0.15  M 
cacodylate buffer,  pH 7.3.  Small fragments of tissue  (1-mm  3) were post-fixed in 1.3%  OsO4 in s- 
collidine buffer for 1 h  at 4°C.  They were dehydrated  in graded alcohol, and embedded in Epon. 248  CELL-MEDIATED  GLOMERULAR  INJURY 
Thin sections were cut, picked up on carbon-coated grids, and stained with uranyl acetate and 
lead citrate.  They were examined in a  Philips EM-300 electron microscope  (Philips Electronic 
Instruments, Inc., Mount Vernon, N. Y.). 
For light mcroscopy, thin slices of renal cortex obtained immediately after sacrifice were fixed 
in 10% buffered formalin, embedded in paraffin, cut at 4 ~m, and stained with hematoxylin and 
eosin. 
Statistical  analysis.  The observed counts were transformed to stabilize the variances using a 
square-root  transformation  (17).  Groups  within  an  experiment  were  compared  by  one-way 
analysis of variance on the transformed data,  and then the statistical significance between all 
pair-wise comparisons of group means was performed by Tukey's t  test (18).  This test was used 
instead of the standard Student's t  test,  because it takes into consideration the fact that more 
than two groups are to be compared. The means of the transformed data were squared to convert 
them to the original counts, and are shown in the tables as "mean converted to original scale". 
The level of significance used wasP <  0.05. 
Results 
Experiment I.  The  basic  aim  of this  experiment  was  to determine  if the 
transfer  of lymph node cells from rats  sensitized to RGG into nonimmunized 
recipients that had received subnephritogenic doses of rabbit anti-GBM antise- 
rum  (and which had  therefore RGG fixed in their glomeruli)  would result  in 
glomerular lesions. Normal Lewis rats were injected intravenously with 0.5 or 
1.0 ml of anti-GBM antiserum  (pool A). 24 h later, these animals were divided 
into  five groups which were treated  as follows: rats  in  groups  I  and  II were 
injected  intravenously  with  400-500  x  106  lymph  node  cells  from  donors 
immunized  with  RGG or OVA,  respectively;  rats  in  groups  III  and  IV were 
injected with 7 ml of sera (4 ml intraperitoneally  and 3 ml intravenously) from 
the RGG or OVA donors,  respectively; rats in group V  were injected intrave- 
nously with 2 ml of HBSS. Rats in group VI were not given anti-GBM antiserum 
and  received  only  HBSS  (2  ml  intravenously).  Most  of the  animals  were 
sacrificed 48 h after the time of transfer; a few were killed at 96 h. 
HISTOLOGIC FINDINGS (TABLE I).  Unequivocal histologic abnormalities in the 
kidneys were found only in rats that received anti-GBM antiserum followed by 
lymph node cells from donors immunized with RGG (group I); among rats killed 
48 h  after cell transfer,  abnormalities  were seen in  11 surviving rats  (from a 
group of 12) that had received 1 ml of anti-GBM antiserum,  and in two of four 
animals that had received 0.5 ml. The abnormalities were confined to glomeruli. 
The lesions were irregular and were characterized by segmental hypercellular- 
ity in most glomeruli  (Fig.  1) and by segmental necrosis in a  small percentage 
of glomeruli (Fig. 2). Two additional rats (not shown in Table I) received 1 ml of 
anti-GBM serum and were killed 96 h  after cell transfer;  in both, more severe 
glomerular  abnormalities  were  seen,  affecting  all  glomeruli.  The  areas  of 
hypercellularity contained mononuclear cells, but it could not be determined to 
what extent they were infiltrating cells or mesangial and endothelial cells that 
had proliferated. 
Several donor and recipient rats (in group I) were skin tested 24 h before sacri- 
fice with 25-100 ~g of RGG. Histologic sections of the sites obtained 24 h  after 
challenge  showed inflammatory  reactions with a  predominantly  mononuclear 
cell infiltrate,  consistent with delayed hypersensitivity reactions. 
IMMUNOFLUORESCENCE  FINDINGS.  In  all  rats  that  received rabbit  anti-rat 
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TABLE  I 
Experiment I: Renal Histologic and Immunofluorescence Findings in Rats Given Anti- 
GBM Antiserum with or without Cell or Serum Transfer 24 h Later* 
Number 
Amount of  with histo- 
anti-GBM  Number of 
Experimental group  antiserum  animals  logic  glo- 
merular le- 
(pool  A)  sions 
Linear GMB  staining 
RGG  Rat IgG 
I. Anti-GBM antiserum +  i  ml  125 
LN cells  from RGG  donors§  0.5  ml  4 
II. Anti-GBM antiserum +  i  ml  4 
LN cells  from OVA  donors  0.5  ml  4 
III. Anti-GBM  antiserum +  se-  1  ml  8 
rum from RGG  donors 
IV.  Anti-GBM antiserum +  se-  1 ml  3 
rum from OVA donors 
V.  Anti-GBM antiserum +  1 ml  12 
HBSS  0.5 ml  4 
VI.  HBSS  none  8 
11  ++++  + 
2  ++++  + 
0  ++++  0 
0  ++++  0 
0  ++++  ++ 
0  ++++  0 
0  ++++  0 
0  ++++  0 
0  0  0 
*  Animals were sacrificed 48 h after the time of transfer. 
*  One animal died before the end of the experiment. 
§  Donors had been immunized 7 days earlier with 100 ~g of RGG or OVA. 400-500  x  106 lymph 
node  (LN)  cells or 7  ml of serum were transferred. Serum from rats immunized with RGG 
contained 0.14 mg anti-RGG antibedy/ml. 
FIG.  1.  Segmental increase in cellularity of a  glomerulus from a  recipient of 1.0 ml of 
anti-GBM  antiserum  and  lymph  node  cells from  donors  sensitized to  RGG  (group  I, 
experiment I). Hematoxylin and eosin used for staining, x  630. 250  CELL-MEDIATED GLOMERULAR INJURY 
FIG.  2.  Segmental  necrosis  in  a  glomerulus  from  a  recipient  of  1.0  ml  of anti-GBM 
antiserum  and  lymph node cells from donors sensitized to RGG (group I, experiment I). 
Hematoxylin and eosin used for staining,  x  630. 
the GBM (Table I). The animals in group III (anti-GBM antiserum plus serum 
from RGG donors) also showed, as anticipated, linear staining (2+) for rat IgG. 
Unexpectedly, the rats in group I, (anti-GBM antiserum followed by cells from 
RGG donors)  also showed linear  GBM staining  for rat  IgG (1+).  This finding 
led to another group of experiments,  as described below. In addition, there was 
mild, focal granular mesangial staining for rat IgG in animals in all groups; this 
appeared to be slightly more intense in the animals  in group I.  In none of the 
animals  was there appreciable  C3 staining  in glomeruli.  Irregular,  generally 
mild staining with anti-fibrinogen  serum was seen in the glomeruli of some of 
the animals in group I, apparently in areas of segmental necrosis. 
AUTORADIOGRAPHIC  STUDIES.  Autoradiographic studies were also performed 
on renal tissue of the animals described above; the recipient rats received three 
injections of [3H]thymidine  at  18, 27,  and 44 h  after the time of transfer.  The 
results  of these  studies  confirmed  the  histological  observations  by revealing 
increased numbers of labeled cells within glomeruli  in the rats  in group I; in 
addition,  the autoradiographs revealed significant increases in other groups in 
which  definite  histologic  changes  had  not  been  apparent  (Table  II).  Thus, 
appreciable increases in labeled cells were found in the glomeruli of all animals 
that  had received anti-GBM serum,  as compared with rats injected only with 
HBSS (group VI).  The animals  given 1 ml of anti-GBM serum had about one 
and a half times as many labeled cells in glomeruli as those given 0.5 ml. For a 
given dose of anti-GBM  antiserum,  the rats  in group I  (anti-GBM  antiserum 
plus  lymph  node  cells  from  RGG  donors)  were  found  to  have  significantly BHAN,  SCHNEEBERGER,  COLLINS, AND  McCLUSKEY 
TABLE II 
Experiment I: Number of Labeled Cells in Glomeruli* 
251 
Group I:  Group II:  Group HI:  Group IV: 
Anti-  Anti-  Anti-  Anti-  Group V: 
Amount of anti-  GBM an-  GBM an-  Anti-  GBM an-  GBM an-  GBM antiserum  tiserum  tiserum  GBM an-  tiserum  tiserum  (Pool A)  + LN  + LN  tiserum  + serum  + serum  cells  cells  + HBSS  (RGG)  (OVA) 
(RGG)  (OVA) 
Group VI: 
HBSS 
only 
Pooled 
estimate 
of SD for 
all groups 
excluding 
VI 
l ml 
Number  of  la-  633  247  292  177  312 
beled  cells/100  700  275  340  193  100 
glomeruli  639  233  613  215  147 
272  304  320 
45 
50 
43 
44 
Mean  in trans-  25.63  16.01  19.43  13.95  14.42 
formed  scale* 
6.74  ___2.62 
Mean  con- 
verted to origi- 
nal scale 
657  256  378  195  208  45 
0.5ml 
Number  of  la-  348  144  N.D.§  N.D.  104  34 
beled  cells/100  445  143  N.D.  N.D.  100  51 
glomeruli  415  137  N.D.  N.D.  156  37 
407  136  N.D.  N.D.  84  49 
Mean  in trans-  20.07  11.83  10.46  6.51  ±1.02 
formed scale 
Mean  con- 
verted to origi- 
nal scale 
403  140  109  42 
* 1 uCi of [3H]thymidine/g body weight was given at 18, 27, and 44 h after transfer of lymph node 
(LN) cells  or  serum. Autoradiographs  were exposed  for  2  wk. 
* Mean obtained from square-root transformation of observed counts. Statistical  significance 
(Tukey's t  adjusted for  making all possible  comparisons): group I  vs. II, IV, V, and VI = P  < 
0.05.  Group I  vs. III= not significant. 
§ N.D., not  determined. 
greater numbers  of labeled cells than any of the other groups. The animals with 
the next highest  numbers  were in group III (anti-GBM  antiserum  plus serum 
from RGG donors). 
Autoradiographs  of 1-/~m thick plastic-embedded  sections were examined  at 
×  1,000  magnification  to  determine  the  precise  location  and  nature  of the 
labeled cells in glomeruli. 6-20 glomeruli from each of two animals  from all of 
the five groups were studied. Cells lining the capillary lumen whose nuclei were 
toward  the  mesangial  region were provisionally identified as endothelial  cells 
(Fig.  3).  Rats  receiving  anti-GBM  antiserum  followed by  serum  from  donors 
immunized  with  RGG  (group  III) had  the  greatest  increase  in  the  number  of 
labeled cells identified as endothelial cells. Except for the normal  control rats, 
all animals  had labeled cells present within the mesangium  as well, and these 252  CELL-MEDIATED GLOMERULAR INJURY 
FIG.  3.  Autoradiograph of a glomerulus from a rat that had received 1.0 ml of anti-GBM 
antiserum and serum from donors sensitized to RGG (group III, experiment I). Many of the 
labeled cells are endothelial cells or are attached to endothelial cells (arrow heads),  x 
1,000. 
were particularly numerous in group I, and to a lesser extent in group III (Fig. 
4).  A  few labeled cells were  seen within glomerular capillary lumens in  all 
animals, including the normal controls. There were no labeled epithelial cells 
in glomeruli in any of the groups. 
ELECTRONMICROSCOPIC  OBSERVATIONS.  The  most  severe  ultrastructural 
changes  in  glomeruli  were  seen  in  the  animals  from  group  I  (anti-GBM 
antiserum plus RGG cells). The endothelial cells were prominent, and showed 
increased  amounts  of  rough  endoplasmic  reticulum  (RER).  However,  the 
endothelium was intact in all glomeruli examined, and fenestrae were readily 
identified.  In  several  capillary  loops,  a  neutrophil  and/or  a  monocyte was 
wedged between the glomerular basement membrane and the overlying endo- 
thelium. Such cells were also seen free within capillary lumens. The mesangium 
contained increased numbers of cells, some of which had ultrastructural fea- 
tures of monocytes or macrophages, including an oval nucleus with peripherally 
clumped chromatin, and a moderate to a large amount of cytoplasm containing 
a few lysosomes. Also present were cells with a moderate amount of cytoplasm, 
an  oval  nucleus,  and  moderate  amounts  of RER;  these  cells  could  not  be BHAN,  SCHNEEBERGER,  COLLINS~ AND  McCLUSKEY  253 
FIG. 4.  Autoradiograph  of  a glomerulus  from  a rat  that  had  received  1.0  ml of  anti-GBM 
antiserum  and  lymph  node  cells  from  donors  immunized  with  RGG  (group  I,  experiment  I). 
Most of  the labeled  cells  are in  the mesangium (arrow  heads), x 1,000. 
classified.  In some areas,  mesangial  cells were seen extending long processes 
to neighboring  capillaries;  the  processes contained  bundles of microfilaments 
(Fig. 5). Similar changes were seen in glomeruli in the other four experimental 
groups  (groups  II-V),  although  fewer cells  were  present  in  the  mesangium, 
particularly  in those animals  receiving anti-GBM  antiserum  alone  (group V). 
In the control animals  (group VI), only a  single cell resembling a  macrophage 
was observed in the mesangium of one glomerulus. No mesangial deposits with 
features suggesting immune complex depositio, were found in any of the groups. 
Experiment H.  To  explore  the  possibility  that  T-cell  preparations  were 
capable of inducing glomerular abnormalities similar to those seen with whole 
lymph node cell preparations,  an experiment was carried out employing lymph 
node cells enriched in T cells, prepared by the use of nylon wool columns (13). 
Lewis rats were given 0.5 ml of anti-GBM  antiserum  (pool B); 24 h  later,  the 
animals were divided into three groups. The rats in group IA were given 400  x 
106  lymph  node  cells from  RGG donors;  those  in  group  IIA,  200  x  106  of T- 
enriched cells from RGG donors (which we estimated to be less than the number 
of T cells present in the whole lymph node preparation);  and rats in group IIIA 
received  HBSS;  the  rats  in  group  IVA  were  injected  with  HBSS  alone.  All FIG.  5.  Electronmicrograph of a portion of a glomerulus from a rat that had received anti- 
GBM  antiserum  and  lymph  node  cells  from  donors  immunized  with  RGG  (group  I, 
experiment I). The endothelial cell (E) is prominent and contains abundant  endoplasmic 
reticulum  (RER).  Two monocytes  (M)  are  present  in  the  capillary  lumen,  and  contain 
substantial  RER and few granules.  Two other cells with the morphological appearance of 
monocytes  (M') are present immediately below the endothelium and  in the mesangium. 
Another endothelial cell (E') borders a partially compressed capillary lumen,  x  7,900. 
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TABLE  III 
Experiment II: (T-Cell Transfer) Number of Labeled Cells in Glomeruli 
255 
Pooled es-  Group IA:  Group IIA: 
anti-GBM  anti-GBM  Group IIIA:  timate of 
anti-GBM  Group IVA:  SD for all  antiserum*  antiserum 
+ LN cells$  + T cells§  antiserum  HBSS only  groups ex- 
(400 × 106)  (200 × 106)  + HBSS  cluding 
group IV 
Number oflabeled cells]100 glo-  118  115  60  37 
merulill  149  115  69  30 
121  84  46  36 
230  126  79  35 
Mean in transformed scale¶  12.31  10.46  7.93  5.87  -+1.37 
Mean converted to original scale  152  109  63  34 
* Each animal received 0.5 ml of anti-GBM antiserum (pool B). 
Whole lymph node (LN) cell suspensions  from RGG donors. 
§ T-cell-enriched suspensions from RGG donors obtained by use of nylon wool columns. 
II Each animal received  [3H]thymidine  at 18,  27,  and 44 h after cell transfer. Autoradiographs 
were exposed for 2 wk. 
¶ Mean  obtained from square-root transformation of observed  counts.  Statistical  significance 
(Tukey's t adjusted for making all possible comparisons): group IA vs. IIIA and IVA = P < 0.05. 
Group IA vs. group IIA = not significant. 
animals  received  [3H]thymidine  at  18,  27,  and  44  h  after  cell  transfer.  No 
definite histologic abnormalities were found  (in comparison with experiment I 
in which all animals receiving 1.0 ml of anti-GBM antiserum showed histologic 
lesions,  in  experiment  II,  the  animals  received  only  0.5  ml  of  anti-GBM 
antiserum;  this  was  done  to  reduce  the  background  injury  from  anti-GBM 
antibodies;  furthermore,  a  different  pool  was  used).  Immunofluorescence  re- 
vealed linear GBM staining for rabbit and rat IgG in groups IA and IIA, and for 
rabbit IgG only in group IIIA. In autoradiographs,  it was found that  animals 
given  either  lymph  node  cells  or  T-enriched  cells  showed  appreciably  more 
labeled cells than those given anti-GBM antiserum alone (Table III) and there 
was no significant difference between groups IA and IIA. It should be noted the 
pool B  anti-GBM antiserum  (group IIIA) did not result in as great an increase 
in labeled cells as pool A, which was used in experiment I. 
Experiment III.  As noted above, the rats in group I  in experiment I  (anti- 
GBM antiserum  plus lymph node cells from RGG donors) were found to have 
linear  GBM  accumulation  of  rat  IgG,  indicating  that  they  had  produced 
antibodies against RGG. Since this group received an intravenous injection of a 
large number of lymph node cells, many of which were activated, we considered 
the  possibility that the  glomerular abnormalities resulted not entirely from a 
reaction of specifically sensitized cells with RGG fixed in glomeruli, but from a 
reaction  of some of the  injected  lymph node  cells of various  specificities with 
glomerular  basement  membrane-bound  immune  complexes  consisting  of rat 
IgG and RGG. To explore this possibility, the following studies were performed. 
Preliminary  observations  showed  that  the  injection  of 0.5  ml  of serum  from 
RGG  donors  (containing  0.14  mg/ml  antibody  protein)  into  rats  that  had 
received  rabbit  anti-GBM  antiserum  24  h  earlier  resulted  in  linear  GBM 256  CELL-MEDIATED  GLOMERULAR  INJURY 
TABLE  IV 
Experiment III: Labeled Cells in Glomeruli 
Group IB:  Group IIB:  Group IIIB: 
anti-GBM  anti-GBM 
Anti-GBM  Group IVB:  antiserum  antiserum 
antiserum  HBSS + 
+  LN cells  +  LN cells 
+  HBSS +  anti-RGG  (RGG) +  (OVA) + 
anti-RGG  antiserum  anti-RGG  anti-RGG 
antiserum 
antiserum*  antiserum 
Pooled es- 
timate of 
SD for all 
groups, ex- 
cluding 
IVB 
Number oflabeled cells/100 glo-  377  127  152  52 
meruli  173  112  97  28 
233  65  124  56 
157  126  84 
172 
Mean in transformed scales  14.70  10.28  10.62  6.66  ___2.24 
Mean converted to original scale  216  106  113  44 
* Each  animal in groups  IB,  IIB,  and  IIIB received 0.5 of anti-GBM antiserum  (pool  B),  and 
animals in all groups received 0.5 ml of serum from animals immunized 7 days previously with 
RGG in CFA, 24 h after lymph node (LN) transfer and [3H]thymidine administration. 
S Mean  obtained  from  square-root  transformation  of observed  caunts.  Statistical  significance 
(Tukey's t  adjusted for making all possible comparisons): group IB vs. group IIB= P  <  0.05. 
staining for rat IgG with about the same intensity (1+) as had been observed in 
group I in experiment I. Additional rats were then injected intravenously with 
0.5  ml  of rabbit  anti-GBM  antiserum;  24  h  later,  two  groups  (IB  and  IIB) 
received 400  ×  106 lymph node cells from RGG or OVA donors, respectively; at 
48 h, each group was given 0.5 ml of the serum containing anti-RGG antibodies 
that had been tested earlier; the animals were killed at 72 h. Rats in group IIIB 
received the same injections of antisera,  but were not given lymph node cells. 
Rats in group IVB received no anti-GBM  antiserum  or lymph node cells, but 
were given  0.5 ml  of rat  anti-RGG antiserum.  All the  animals  were injected 
with  [3H]thymidine  at  18,  27,  and  44  h  after  the  time  of cell  transfer.  By 
immunofluorescence, linear  GBM staining  for rabbit and rat IgG was seen in 
animals  in  groups  IB,  IIB,  and  IIIB.  In  histologic  preparations,  no  definite 
abnormalities were found, although there was equivocal glomerular hypercel- 
lularity in the rats in group IB. The results of the autoradiographic studies are 
shown in Table IV. As before, increased numbers of labeled cells were found in 
all animals that received anti-GBM antiserum,  as compared with the controls 
(group IVB).  However, the greatest increase was seen in animals  in group IB 
(antisera plus RGG lymph node cells), and there were no significant differences 
between groups IIB (antisera  plus OVA lymph node cells) and  IIIB  (antisera 
only). 
Discussion 
We have shown that the transfer of lymph node cells from rats sensitized to 
RGG into syngeneic recipients with RGG fixed in their glomeruli  (present as 
anti-GBM antibodies in amounts too small to produce histologically detectable 
lesions) results  in glomerular  hypercellularity,  sometimes together with  seg- BHAN,  SCHNEEBERGER,  COLLINS, AND  McCLUSKEY  257 
mental necrosis. In support of the interpretation that these abnormalities were 
produced by a hypersensitivity reaction of the cell-mediated (delayed) type, are 
the following observations: (a) the reaction exhibited specificity, as shown by 
the finding that cells from donors sensitized to an unrelated antigen (OVA) 
failed to result in abnormalities; (b) T-cell-enriched cell suspensions from RGG 
donors  were  effective in  producing  the  reaction;  (c)  both  the  donors  and 
recipients of lymph node cells exhibited delayed-type  hypersensitivity reactions 
after  intradermal  challenge  with  RGG;  (d)  the  glomerular reactions  were 
characterized by accumulation of mononuclear cells. 
The recognition and characterization of the glomerular abnormalities were 
greatly facilitated by autoradiographic studies of renal tissue obtained from the 
recipients, which had been given [~H]thymidine after cell or serum transfer. In 
many animals, significant increases in the number of labeled cells in glomeruli 
were  demonstrated  even  though  no  definite  histologic  abnormalities  were 
present. Aside from the fact that it is easier to count a relatively small number 
of labeled cells in glomeruli rather than the total number, autoradiographic 
studies permit detection of cells that have proliferated; some of these cells might 
have replaced destroyed cells, and this would not necessarily contribute to an 
increase in the overall number of glomerular cells.  The labeled cells found in 
glomeruli could represent either glomerular cells that had proliferated, or cells 
that were labeled while proliferating in the bone marrow, lymphoid tissue, or 
circulation, which subsequently localized in glomeruli. However, the timing of 
injections of [aH]thymidine used in the present experiments, which began after 
transfer, would probably favor the labeling of proliferating glomerular cells 
rather than infiltrating cells.  Nevertheless, electron microscopic observations 
favor the interpretation that most of the increase in mesangial cells seen in 
group I resulted from an influx of mononuclear cells (probably monocytic) from 
the circulation, rather than from proliferation of mesangial cells.  However, 
definite proof concerning the nature of these cells must await studies in which 
distinctive cell markers are identified. 
In the model employed, there was an underlying component of glomerular 
injury produced by the rabbit anti-GBM antiserum, even though this was not 
detected in histologic sections; thus,  increased numbers of labeled cells were 
found in glomeruli in all groups given anti-GBM antiserum, as compared with 
normal  control  rats.  Furthermore,  in  two  groups  there  also  occurred  the 
combination of rat anti-RGG antibodies with glomerular-bound RGG,  as evi- 
denced by linear GBM staining for rat IgG.  In group III this was anticipated, 
since  anti-RGG  antibodies  were transferred.  Unexpectedly, rats  in  group  I 
(anti-GBM antiserum plus RGG cells)  also exhibited linear GBM staining for 
rat IgG.  However, it does not seem that the antibodies found in these animals 
could have accounted for all the glomerular abnormalities, since rats in group 
III which received large amounts of rat anti-RGG antisera (and which showed 
very intense  GBM  staining  for rat  IgG)  failed to  develop abnormalities of 
comparable severity and appearance. The possibility that the increased glomer- 
ular  damage  seen  in  group  I  could  have  been  initiated  by  interaction  of 
glomerular  basement  membrane-bound rat  IgG  anti-RGG  complexes  with 
lymphocytes sensitized to irrelevant antigens was considered, because of the 
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animals.  However, this explanation seems unlikely for the following reasons: 
(a) most of the injected cells had probably disappeared from the circulation 
before the time rat  anti-RGG was produced and fixed in  glomeruli; (5)  the 
administration of rat anti-RGG to recipients of rabbit anti-GBM antiserum and 
lymph node cells from OVA donors (group IIB)  failed to produce comparable 
glomerular alterations. 
There remains one other mechanism by which the heightened glomerular 
damage seen in animals in group I might have been antibody-mediated rather 
than cell-mediated; namely through the glomerular deposition of circulating 
immune complexes containing RGG and rat anti-RGG antibodies. Thus, it is 
probable that the amount of rat anti-RGG antibodies formed in the animals in 
group I was sufficiently small to lead to the formation of soluble complexes with 
the RGG still present in the circulation. In contrast, in the animals in group III, 
which received a large amount of rat anti-RGG, large insoluble complexes were 
probably formed, with rapid reticuloendothelial system clearance. Despite these 
considerations, it seems highly unlikely that there was appreciable glomerular 
deposition of immune complexes in the rats in group I, since there was only faint 
irregular mesangial staining for the rat IgG in these animals, and this was only 
equivocally greater than  in  the  other groups.  Furthermore, there were  no 
electron-dense deposits  in  glomeruli  with  features  of  immune  complexes. 
Further evidence against the possibility that the changes in group I were due to 
circulating immune complexes is provided by the finding that rats in group IIB 
(experiment III),  which received small  amounts of rat  anti-RGG  antibodies 
after having received rabbit  anti-GBM  antiserum,  failed to develop similar 
changes. 
The mechanisms by which the cell-mediated reaction mediated the glomeru- 
lar abnormalities are not clear. Based on studies of delayed hypersensitivity 
reactions elicited in the skin, it is reasonable to assume that contact between 
antigen (RGG) and a small number of specifically sensitized cells initiated the 
reaction,  which led  to  the  accumulation of mononuclear phagocytes and  of 
lymphocytes of other specificites (19). In addition, it appears that proliferation 
of glomerular cells was stimulated, possibly through the release of lymphokines. 
Proliferation of endothelial cells has been shown to be a feature of cutaneous 
delayed reactions (20, 21). Although it appears most likely that the glomerular 
changes observed in the present experiments were initiated by contact between 
sensitized cells and antigen (RGG) fixed in glomeruli, it is also possible that 
systemic release of lymphokines, resulting from interaction of sensitized cells 
and RGG in the circulation, may have contributed to the glomerular reaction. 
The relevance of the present observations to other forms of experimental or 
human  glomerular disease  is  uncertain.  The  possibility  that  cell-mediated 
mechanisms may participate in human anti-GBM disease is worth considering, 
in view of the observation that evidence has been obtained from in vitro studies 
indicating that such patients develop cell-mediated reactivity to GBM constit- 
uents  (1,  22). In  addition,  it  may be  that  cell-mediated reactivity against 
exogenous antigens fixed in glomeruli, as in the form of immune complexes, 
could participate in the production of glomerular injury. However, even if they 
occur, definite identification of cell-mediated reactions in human glomeruli may 
not be possible  at present, since there are no reliable morphologic criteria for BHAN,  SCHNEEBERGER,  COLLINS,  AND  McCLUSKEY  259 
identifying such reactions, and since transfer experiments obviously cannot be 
performed in man. 
Summary 
Lewis  rats  were  injected  intravenously  with  rabbit  anti-rat  glomerular 
basement membrane (GBM) antiserum in doses that were sufficient to cause 
glomerular fixation of rabbit gamma globulin (RGG) detectable by immunoflu- 
orescence,  but  which failed to  induce  histologically detectable  lesions.  24  h 
later, groups of rats received lymph node cells or serum from syngeneic donors 
that had been immunized with either RGG or ovalbumin; they were injected 
with [3H]thymidine three times during the next 2 days, and sacrificed 48 or 96 h 
after transfer. Only the rats given anti-GBM antiserum plus lymph node cells 
from donors sensitized to RGG showed histological glomerular lesions, in the 
form of segmental hypercellularity and necrosis. Autoradiographs revealed the 
greatest number of labeled cells in glomeruli in the same group. In analogous 
experiments, it was shown that T-cell-enriched populations could induce hyper- 
cellular glomerular reactions. On the basis of electronmicroscopic and autora- 
diographic observations,  it  appears  that  the  glomerular hypercellularity re- 
sulted from both infiltration of mononuclear cells and proliferation of endothe- 
lial cells. The findings indicate that interaction of  specifically sensitized lympho- 
cytes with glomerular-bound antigen can induce a cell-mediated (delayed-type) 
reaction in glomeruli. 
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